Hospital La Paz Institute for Health Research

What Hospital La Paz Institute for Health Research does

Hospital La Paz Institute for Health Research (IdiPAZ) is a Spanish biomedical research institute operated by the private non-profit foundation FIBHULP (Fundación para la Investigación Biomédica del Hospital Universitario La Paz), founded in December 2003 and physically embedded within the Hospital Universitario La Paz complex in Madrid. Its core activity is translational and clinical research organized across nine scientific areas: neurosciences and mental health, cardiovascular, infectious diseases and immunity, large system pathologies, cancer and human molecular genetics, surgery and transplantation, maternal-infant and adolescent health, and multidisciplinary aging research. The institute serves hospital-affiliated clinical staff and researchers together with partner institutions including Universidad Autónoma de Madrid, Universidad Europea, and Hospital Universitario de Getafe, coordinating shared infrastructure and institutional funding access.

IdiPAZ runs a portfolio of internal technology platforms that constitute its core "product surface": a Biobanco biorepository, a next-generation DNA/RNA sequencing platform, flow cytometry with a spectral sorter, a molecular imaging and immunohistochemistry unit, a BSL-2 virology laboratory, bioinformatics and biostatistics support, an experimental surgery and animal facility, a 3D management laboratory, and the SimuPAZ clinical simulation center offering EPALS and advanced life support courses. Around these platforms it operates the UICEC clinical trials unit, the UAI innovation support unit with an OTC technology transfer office, an Open Science policy, and recurring scientific seminars and training programs.

The institute does not generate commercial revenue from products or services. Its operating model is grant- and subsidy-funded: an annual nominal subsidy (subvención nominativa) from the Consejería de Sanidad de la Comunidad de Madrid covers institutional operations and researcher stabilization, supplemented by competitive grants from the Instituto de Salud Carlos III, the Ministerio de Ciencia e Innovación, and European Union instruments including Next Generation EU. Outputs are disseminated via peer-reviewed publications, conference presentations, the IdiPAZ News newsletter, and formal training programs rather than via commercial channels.

Name

Hospital La Paz Institute for Health Research

Legal name

Fundación para la Investigación Biomédica del Hospital Universitario La Paz

Website

https://idipaz.es

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

IdiPAZ is a non-profit biomedical research institute in Madrid, operated by the FIBHULP foundation within Hospital Universitario La Paz. It runs nine clinical research areas and shared platforms (biobank, sequencing, bioinformatics, clinical trials, simulation) serving hospital researchers and partner universities.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Biomedical research services
• Clinical trials management
• Translational medicine research
• Biobank services
• Health research institute

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Distribution channels1 record

Marketing channels4 records

Core offering

IdiPAZ is a biomedical and health research institute organized around nine specialized scientific areas (neurosciences, cardiovascular, infectious diseases, large system pathologies, cancer and human molecular genetics, surgery/transplantation, maternal-infant health, and aging). It provides researchers with shared scientific platforms—including Biobank, next-generation sequencing, flow cytometry, bioinformatics, molecular imaging, clinical simulation (SimuPAZ), experimental surgery, and a Clinical Trials Unit (UICEC)—alongside administrative, funding, and technology-transfer support managed through its foundation FIBHULP.

Product overview

IdiPAZ (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) is a biomedical research institute organized as a platform of interconnected research services and support units. The core offering consists of scientific research across nine specialized areas (Neurosciences, Cardiovascular, Infectious Diseases, Large System Pathologies, Cancer and Human Molecular Genetics, Surgery/Transplants, Maternal-Infant Health, and Aging Research), supported by technical platforms including Biobank, Sequencing, Bioinformatics, Simulation (SimuPAZ), and Clinical Trials Unit. The institute also provides training programs, scientific seminars, and innovation transfer services, functioning as an integrated research ecosystem rather than a traditional product company.

Differentiator

Problem solved

Functional benefit

Products and services

• IdiPAZ Scientific Research Services
• Clinical Trials Unit (UICEC)
• SimuPAZ Clinical Simulation Training
• Innovation Support Unit (UAI) and Technology Transfer Office (OTC)
• Research Support Platforms (Biobank, Sequencing, Bioinformatics, Flow Cytometry, Imaging)

Quantifiable outcome

• Multiple high-impact scientific publications annually across diverse research areas (2024 publications in cancer, neuroscience, cardiovascular, infectious diseases, pediatrics, aging)
• +1 more outcomes

Segments2 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered core and secondary.

• Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP)coreStrategic or Co-development PartnerFIBHULP is the founding and managing foundation of IdiPAZ, providing administrative, financial, and operational support for the institute's research activities. FIBHULP manages funding, human resources, legal compliance, and institutional relations on behalf of IdiPAZ.
• Universidad Autónoma de Madrid (UAM)coreStrategic or Co-development PartnerAcademic partner providing research collaboration, doctoral programs, and access to university researchers and facilities. UAM is a key institutional partner in the IdiPAZ consortium.
• Hospital Universitario La PazcoreStrategic or Co-development PartnerThe main clinical partner providing access to patient populations, clinical data, and clinical researchers. IdiPAZ is physically located within the hospital complex.
• Hospital Universitario de GetafesecondaryStrategic or Co-development PartnerAffiliated hospital providing additional clinical research capacity and collaborative opportunities within the healthcare network.
• Universidad EuropeasecondaryStrategic or Co-development PartnerPrivate university partner contributing to research collaboration and training programs.

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Charles River Laboratories: Global contract research organization offering preclinical, clinical, and manufacturing services. Not a hospital-based peer, but a relevant comparator for IdiPAZ's UICEC clinical trials unit and biostatistics platform as scaled, commercially-operated alternatives in the same translational research space.
• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences with sites across Europe. Not a hospital-based research institute, but a relevant comparator for IdiPAZ's genomics, bioinformatics, and molecular imaging platforms at a much larger scale.

Direct peers

• Vall d'Hebron Institut de Recerca (VHIR): Spanish hospital-based biomedical research institute affiliated with the Vall d'Hebron University Hospital in Barcelona. Structurally near-identical to IdiPAZ: multi-area translational research, shared research platforms, public funding, and consortium governance with academic and hospital partners.
• Institut d'Investigació Biomèdica de Bellvitge (IDIBELL): Catalan hospital-linked research institute combining basic, translational, and clinical research across multiple scientific areas. Shares the IdiPAZ operating template: public funding, consortium governance, and integrated hospital-research infrastructure.
• Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS): Barcelona-based biomedical research consortium linked to Hospital Clínic and the University of Barcelona. Operates a comparable model of multi-area translational research, shared platforms (biobank, bioinformatics, clinical trials), and competitive public grant funding — making it one of IdiPAZ's closest structural peers.
• Centro Nacional de Investigaciones Cardiovasculares (CNIC): Spanish national research center focused on cardiovascular disease, also funded by public grants and a foundation model. Comparable in scale and translational orientation, and overlaps with IdiPAZ's cardiovascular research area.
• Centro de Investigación Biomédica en Red (CIBER): Spanish nationwide consortium of biomedical research groups funded by Instituto de Salud Carlos III. Many IdiPAZ researchers are CIBER members, making CIBER both a collaborator and a direct alternative channel for public biomedical research funding in Spain.
• Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM): Madrid-based hospital research institute affiliated with Hospital Gregorio Marañón. Operates the same model as IdiPAZ within the same regional public health system, making it a direct local competitor for researchers, grants, and clinical-trial contracts.
• Centro Nacional de Investigaciones Oncológicas (CNIO): Spain's national cancer research center, operating as a publicly-funded foundation. Overlaps with IdiPAZ's cancer and human molecular genetics area and competes for the same national grant pools.

Regional players

• Centro de Investigación Biomédica de La Rioja (CIBIR): Smaller regional biomedical research center in La Rioja, Spain. Operates a similar translational research and shared-platform model but at a smaller scale; not a direct competitor in the same metro market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fundaci-n-para-la-investigaci-n-biom-dica-hulp

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospital La Paz Institute for Health Research